<DOC>
	<DOCNO>NCT02555150</DOCNO>
	<brief_summary>The purpose randomize , double-blind , crossover study compare two long-acting stimulant formulations—once-daily PRC-063 once-daily lisdexamfetamine ( LDX ) —through 15-hour period drive performance , measure drive simulator , adult patient ADHD .</brief_summary>
	<brief_title>A Comparison PRC-063 Lisdexamfetamine Driving Performance Adults With ADHD</brief_title>
	<detailed_description>Young adult driver Attention Deficit Hyperactivity Disorder ( ADHD ) compare drive simulator take PRC-063 LDX repeated-measure , randomize , doubleblind , crossover study design . Each subject randomize receive 21-day course PRC-063 follow 21 day course LDX vice versa . There washout treatment . On day 1 7 , subject receive low dose ( 45 mg PRC-063 30 mg LDX ) study medication . On day 8 14 , subject receive middle dose ( 70 mg PRC-063 50 mg LDX ) . On day 15 21 , subject receive high dose ( 100 mg PRC-063 70 mg LDX ) . During Days 1 21 , subject respond satisfactorily medication , may remain daily dose . Driving laboratory test conduct Day 17 Day 21 . Following laboratory test , subject begin second titration alternate treatment , start Day 22 Day 28 low dose ( 45 mg PRC-063 30 mg LDX ) study medication , Day 29 Day 35 middle dose ( 70 mg PRC-063 50 mg LDX ) Day 36 Day 42 high dose ( 100 mg PRC-063 70 mg LDX ) . During Days 22 42 , subject respond satisfactorily medication , may remain daily dose . Following titration second treatment , subject attend second drive laboratory testing , conduct Day 38 Day 42 . Subjects subsequently attend safety study termination visit .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Male nonpregnant , nonnursing female least 18 year age less equal 25 year age valid driver 's license least six month drive experience driving activity least twice per week . ADHD diagnosis , inattentive , hyperactive/impulsive combine , define Diagnostic Statistical Manual Mental Disorders , 5th Edition ( DSM5 ) base clinician assessment use Structured Clinical Interview DSM Disorders ( SCID ) . Dissatisfaction current pharmacological therapy treatment ADHD currently receive pharmacological therapy ADHD . Inclusion subject naïve pharmacological therapy ADHD permit . Known nonresponsive methylphenidate lisdexamfetamine treatment . Nonresponse define methylphenidate lisdexamfetamine use various dos phase least four week dose little clinical benefit last 10 year . Having history motion , sea big screen ( e.g . IMAX ) sickness , order avoid possible Simulation Adaptation Syndrome . Subject know family history sudden cardiac death ventricular arrhythmia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>